Rationale and background: Lead [Pb(II)] affects the higher functions of the central nervous system and undermines brain growth, preventing the correct development of cognitive and behavioral functions at exceedingly low levels of exposure.
Introduction
Lead is the most widely used metal, the use of lead compounds still play an important role in modern industry. There has been a marked increase in its use since the 1950s. Despite widely applied restrictions on major uses of lead (e.g.., gasoline additives, paints, and cans); the current annual worldwide production is approximately 5.4 million tons, 23% of which is produced in the United States. Sixty percent of lead is used for the manufacturing of batteries (automobile batteries, in particular), while the remainder is required for the production of pigments, solder, plastics, cable sheathing, ammunition, and a variety of other extruded products (Fischbein, 1998) .
Lead is a hazardous metal for all humans. Lead toxicity causes hematological, gastrointestinal, and neurological dysfunction. Symptoms are usually noted when blood lead greater than 2 micromoles/L.
Severe or prolonged exposure may also cause chronic nephropathy, hypertension, and reproductive impairment. Lead inhibits some enzymes, alters cellular calcium metabolism, stimulates synthesis of binding proteins in kidney, brain, and bone, and slows down nerve conduction (Patocka & Cerny, 2003) .
It has become increasingly evident that the field of neurotoxicology is not only rapidly growing but also rapidly evolving, especially over the last 20 years. As the number of drugs, environmental, bacterial/ viral agents with potential neurotoxic properties has grown, the need for additional testing has increased. Only recently has the technology advanced to a level that neurotoxicologic studies can be performed without operating in a "black box." Examination of the effects of agents that are suspected of being toxic can occur on the molecular (protein-protein), cellular (biomarkers, neuronal function), and genetic (polymorphisms) level. Together, these areas help to elucidate the potential toxic Results: Cases had statistically significant higher TNF α, IL1 and metalloproteinase-9 than controls.
Conclusion and recommendation:
Lead could produce its neurotoxic effects, presented in the current work by the statistically elevated TNF α, IL1 and metalloproteinase-9, through altering the normal immune pattern of the nervous system. This study had provided important new insights into the molecular mechanisms of metal toxicity and had opened several exciting avenues of research.
profiles of unknown (and in some cases, known) agents. The area of proteomics is one of the fastest growing areas in science and particularly applicable to neurotoxicology (Marchetti, 2003) . with disease activity (Miller et al., 2002) .
The aim of the present study was to evaluate the possible lead-induced neurological affections and their mechanism of occurrence.
Subjects and Methods
This study was carried out on workers in a wet battery factory. Workers exposed to other chemical compounds than Lead, those taking drugs affecting the CNS or immunosuppressing drugs were excluded.
All workers gave their informed consent to participate in the study. Both groups were working 8 hours/ daily, 5 days/weekly and, they were all smokers, non-diabetic, normotensive. All cases were having blue lines in their gums.
Sampling:
Ten milliliters of venous blood were collected from every subject 5ml for detection of blood lead level, other 5ml centrifuged and the serum was stored in the deep freeze at -10˚c till its use. The following investigations were performed for every worker:
Estimation of blood lead levels:
I-Estimation of blood lead levels II-Tumor necrosis factor α (TNF α).
III-Interleukin1 (IL1).

IV-Matrix metalloproteinase (MMP9).
Lead levels were estimated using a flameless atomic absorption spectropho- Briefly serum samples and kit calibrator were incubated with monoclonal antibodies for 2 hours at room temperature.
The resulting immune complexes were bounded on the wall of the plate, the unbounded reactants were removed by washing steps, next the plate was incubated with the enzymatic reagent to develop the color, the absorbance of the color then detected by ELISA reader, finally the concentration of the samples were calculated from the standard curve.
Estimation of MMP-9:
The MMP-9 instant ELISA is an en- 
Results
Descriptive data:
The age in group I & II ranged between 23-52 years and 23-56 years with means of 37 ± 10 and 38 ± 12.1 years respectively ( Table-1 ).
The duration of exposure in group II ranged between 3-36 years with a mean of 16.7 ± 11.8 years ( Table-1) .
The blood lead level in group I & II ranged between 6.2-15 µg/dl and 77-90.1 µg/dl with means of 11.9 ± 2.9 µg/dl and 83 ± 3.8 µg/dl respectively ( Table-1 There was a statistically significant higher recurrent infections (in the form of recurrent styes and recurrent urinary tract infections) in cases than in controls (p<0.0001*) ( Table-2 ).
There was a statistically significant higher motor nerve affection (in the form of motor weakness, wrist and foot drop) in cases than in controls (p<0.0001*) ( Table-2 ).
There was a statistically significant higher cranial nerve affection (in the form of diplopia) in cases than in controls (p<0.037*) ( Table-2 ).
There was a statistically significant higher impotence level in cases than in controls (p<0.037*) ( Table-2 ).
There was a statistically significant higher blood lead level in cases than in controls (p<0.0001*) ( Table-1 ).
There was a statistically significant higher serum MMP level in cases than in controls (p<0.0001*) ( Table-1 ).
There was a statistically significant higher serum TNF α1 level in cases than in controls (p<0.0001*) ( Table-1 ).
There was a statistically significant higher serum IL1 level in cases than in controls (p<0.0001*) ( Table-1) .
Mann-Whitney Comparison Test:
There was no difference in the lead level between cases having sensory, motor, cranial nerve affection and increased intracranial tension and, those with no manifestations concerning these neurological parameters (Table-4 ).
Spearman's Correlation:
There was a positive correlation between the lead level and the duration of exposure, MMP, TNF α1, and IL1 (p<0.01*, p<0.02*, p<0.0001* and p<0.0001* respectively (Table-3 ). 
Discussion
The detrimental effects of lead poisoning have been well known since ancient times, but some of the most severe consequences of exposure to this metal have only been described recently. Lead [Pb(II)] affects the higher functions of the central nervous system and undermines brain growth, preventing the correct development of cognitive and behavioral functions at exceedingly low levels of exposure (Lidsky & Schneider, 2003) .
During the last two decades, advances in behavioral, cellular and molecular neuroscience have provided the necessary experimental tools to begin deciphering the many and complex effects of Pb(2+) on neuronal processes and cell types that are essential for synaptic plasticity and learning and memory in the mammalian brain (Toscano & Guilarte, 2005) .
In the present study, there were statistically significant higher lead levels in group II (cases) when compared to group I (control). Surprisingly enough all exposed cases had blue lines in their gums (lead lines).
Moreover, cases had statistically significant higher tumor necrosis factor α (TNF α) and interleukin1 (IL1) levels when compared to controls.
In our present study, cases (group II) had statistically significant higher recurrent infections, motor and cranial nerve affection and impotence than controls (group I).
Our results were in accordance to those of Zhao & Schwartz (1998) (Marchetti, 2003; Lidsky & Schneider, 2003; Vazquez & de Ortiz, 2004 and Toscano & Guilarte, 2005) .
Another proposed mechanism of lead toxicity is that certain cell adhesion molecules, particularly the cadherins family of Ca(2+)-dependent cell adhesion molecules and the immunoglobulin family of Ca (2+)-independent cell adhesion molecules, may be important early targets on which Pb act to produce its toxic effects affecting learning and memory and, immune responses (Prozialeck, et al., 2002) . (Zawia et al., 2000; Razmiafshari, et al., 2001 and Basha et al., 2003 ).
In the current study, cases had statistically significant higher MMP-9 than controls. Our results were in agreement to those previously obtained by Lahat et al. (2002) . They observed an increase in MMP-9 secretion despite the decrease in glial cell number, exposed to lead, suggesting the involvement of a non-cytotoxic mechanism in the combined Pb and pro- 
MMP-9.
Conclusion and Recommendations:
From this study we can conclude that Lead can produce its neurotoxic effects, presented in the current work by the statistically elevated TNF α, IL1 and metalloproteinase-9, through altering the normal immune pattern of the nervous system. All hardly affected workers should be referred to hospital for treatment, receive chelating agent and should be away from work for a period of time till their improvement.
All exposed workers should be routinely investigated for their MMP9 level every 6 months to pick up early changes before manifest neurological affection.
These studies have provided important new insights into the molecular mechanisms of metal toxicity and have opened several exciting avenues of research.
